We are live on ! Find out more
BLFS icon

BioLife Solutions

75 hedge funds and large institutions have $116M invested in BioLife Solutions in 2020 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 27 increasing their positions, 25 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

8.97% more ownership

Funds ownership: 50.04%59.01% (+9%)

8% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 25

6% less funds holding

Funds holding: 8075 (-5)

19% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 16

30% less capital invested

Capital invested by funds: $168M → $116M (-$51.1M)

96% less call options, than puts

Call options by funds: $7K | Put options by funds: $191K

Holders
75
Holders Change
-5
Holders Change %
-6.25%
% of All Funds
1.65%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.07%
New
13
Increased
27
Reduced
25
Closed
16
Calls
$7K
Puts
$191K
Net Calls
-$184K
Net Calls Change
+$74K
Name Holding Trade Value Shares
Change
Change in
Stake
Wells Fargo
26
Wells Fargo
California
$656K +$68K +4,949 +8%
PCM
27
Perkins Capital Management
Minnesota
$610K -$238K -17,300 -21%
Bank of Montreal
28
Bank of Montreal
Ontario, Canada
$601K +$208K +15,124 +31%
New York State Common Retirement Fund
29
New York State Common Retirement Fund
New York
$584K +$3.13K +228 +0.4%
Squarepoint
30
Squarepoint
New York
$501K +$724K +52,742 New
IP
31
Isthmus Partners
Wisconsin
$479K -$41.1K -2,992 -6%
Millennium Management
32
Millennium Management
New York
$471K -$536K -39,045 -44%
QCMC
33
Quantum Capital Management (California)
California
$448K
PM
34
Penbrook Management
New York
$437K +$259K +18,850 +69%
JP Morgan Chase
35
JP Morgan Chase
New York
$410K +$350K +25,494 +144%
Renaissance Technologies
36
Renaissance Technologies
New York
$372K +$123K +8,946 +30%
Dimensional Fund Advisors
37
Dimensional Fund Advisors
Texas
$363K +$525K +38,239 New
CCA
38
Conestoga Capital Advisors
Pennsylvania
$290K +$10.3K +750 +3%
CS
39
Cannell & Spears
New York
$246K +$107K +7,795 +43%
MFIM
40
Mesirow Financial Investment Management
Illinois
$239K -$3.31K -241 -0.9%
Franklin Resources
41
Franklin Resources
California
$234K
Susquehanna International Group
42
Susquehanna International Group
Pennsylvania
$195K +$282K +20,512 New
Charles Schwab
43
Charles Schwab
California
$175K
Morgan Stanley
44
Morgan Stanley
New York
$161K -$136K -9,913 -37%
Bank of America
45
Bank of America
North Carolina
$160K +$24.6K +1,788 +12%
AllianceBernstein
46
AllianceBernstein
Tennessee
$154K +$79.7K +5,800 +56%
SI
47
Stephens Inc
Arkansas
$152K +$220K +15,999 New
UBS Group
48
UBS Group
Switzerland
$151K +$46.8K +3,406 +27%
Janney Montgomery Scott
49
Janney Montgomery Scott
Pennsylvania
$143K -$35.3K -2,572 -15%
Citadel Advisors
50
Citadel Advisors
Florida
$120K +$173K +12,627 New

BLFS Hedge Fund Activity: Q1 2020 in Review

75 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q1 2020, worth a combined $116M — down 30% from $168M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of BLFS and 13 opened new positions — a net loss of 3 holders — while 25 trimmed existing stakes and 27 added.

The largest buyer was Sentinel Pension Advisors, opening a new position worth an estimated $15.1M. The largest seller was Driehaus Capital Management, exiting entirely with an estimated $7.71M sold.

  • 75 institutional investors held BioLife Solutions (BLFS) as of Q1 2020, down from 80 in Q4 2019.
  • Funds reported $116M of BioLife Solutions stock for Q1 2020, down 30% quarter-over-quarter.
  • 13 funds opened new BioLife Solutions positions in Q1 2020 and 16 closed out, a net change of -3 holders.
  • The largest BioLife Solutions buyer in Q1 2020 was Sentinel Pension Advisors, an estimated $15.1M added.
  • The largest BioLife Solutions seller in Q1 2020 was Driehaus Capital Management, an estimated $7.71M sold.

Based on aggregated 13F filings for Q1 2020.